2245. Oral 5-Day Lefamulin for Outpatient Management of...

Open Forum Infectious Diseases 2019 / 10 Vol. 6; Iss. Supplement

2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study

Schranz, Jennifer, Alexander, Elizabeth, Fitts, David, Mariano, David, Meads, Andrew, Sandrock, Christian, Moran, Gregory J, Gelone, Steven P
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofz360.1923
Date:
October, 2019
File:
PDF, 516 KB
2019
Conversion to is in progress
Conversion to is failed